Gennex Laboratories Limited - Company Profile

Q: Who are the current directors of Gennex Laboratories Limited?

The current directors of Gennex Laboratories Limited are Shilpa Bung, Ranga Rao Pantulu Avasarala, Amudala Sreeramulu Nageswar Rao, Dinesh Kumar Kejriwal, Arihant Baid, China Dharma Rao Sangeetrao, Dilip Raj Singhvi, Laxmipat Baid, Sandeep Kumar Daga.

It is a pharma public limited company based in Medak, Telangana, India, established in 1990.

1990 Medak, Telangana, India Active

Last Updated: December 22, 2025

Access Report

About Gennex Laboratories Limited

Gennex Laboratories Limited, a active public limited company, was established on 29 March 1990 in Medak, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24230TG1990PLC011168. Registered under ROC Roc Hyderabad. it is listed. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹24.29 Cr.

Formerly known as Prudential Pharmaceuticals Limited, Pharmasia Drugs And Chemicals Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹68.50 Cr and a net worth of ₹79.02 Cr. Employing 103 professional, Its leadership includes Shilpa Bung (Director), Ranga Rao Pantulu Avasarala (Director), Amudala Sreeramulu Nageswar Rao (Director). Past directors included Dipankar Dasgupta, Vinod Kumar Baid, Y Reddy Ravinder. It holds ₹65.75 Cr open charges and ₹26.13 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 133,Bollaram Jinnaram, Medak, Telangana, 502325.

Company Details

CIN/LLPIN
L24230TG1990PLC011168
Registration Number
011168
Incorporation Date
29 March 1990
Authorized Capital
₹25.00 Cr
Paid-Up Capital
₹24.29 Cr
ROC Code
Roc Hyderabad
Listing Status
Listed
Company Status
Active

Key Metrics

Authorised Capital ₹ 25.00 Cr as on 22-12-2025
Paid Up Capital ₹ 24.29 Cr as on 22-12-2025
Company Age 35 Year, 10 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 65.75 Cr as on 22-12-2025
Satisfied Charges ₹ 26.13 Cr as on 22-12-2025
Revenue Growth **** 9.44% (FY 2023)
Profit Growth **** 16.20% (FY 2023)
Ebitda **** -14.78% (FY 2023)
Net Worth 79.60% (FY 2023)
Total Assets **** 41.07% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Gennex Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Gennex Laboratories Limited?

Current Directors

Name	Designation	Appointment Date	Status
Shilpa Bung	Director	01 Oct 2024	Current
Ranga Rao Pantulu Avasarala	Director	21 Dec 2020	Current
Amudala Sreeramulu Nageswar Rao	Director	21 Dec 2020	Current
Dinesh Kumar Kejriwal	Company Secretary	20 Apr 2023	Current
Arihant Baid	Managing Director	18 May 2012	Current
China Dharma Rao Sangeetrao	Additional Director	12 Mar 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	12 Apr 2019	Past
Pramod Abcsdd	Director	18 May 2012	Past
Pramod Abcsdd	Director	30 Sep 2024	Past
Pramod Abcsdd	Additional Director	30 Sep 2021	Past
Pramod Abcsdd	Additional Director	30 Sep 2021	Past
Pramod Abcsdd	Cfo	13 Aug 2024	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gennex Laboratories.

Gennex Laboratories Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.44% increase. The company also saw a substantial improvement in profitability, with a 16.2% increase in profit. The company's net worth Soared by an impressive increase of 79.6%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

9.44%

*******

Revenue from Operations

*******

6.35%

*******

Total Assets

*******

41.07%

*******

Profit or Loss

*******

16.20%

*******

Net Worth

*******

79.60%

*******

EBITDA

*******

-14.78%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gennex Laboratories?

In 2023, Gennex Laboratories had a promoter holding of 23.69% and a public holding of 76.30%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹657,450,000.00

Satisfied Charges

₹261,268,000.00

Charges Breakdown by Lending Institutions

Others : 65.71 Cr
Axis Bank Limited : 0.04 Cr

Latest Charge Details

Date	Lender	Amount	Status
24 Sep 2025	Others	₹1.50 Cr	Open
22 Nov 2024	Others	₹6.65 Cr	Open
01 Oct 2024	Others	₹5.00 Cr	Open
31 Oct 2023	Others	₹2.25 M	Open
02 Mar 2023	Axis Bank Limited	₹0.40 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Gennex Laboratories?

Gennex Laboratories has a workforce of 103 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Gennex Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gennex Laboratories's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gennex Laboratories

Recent Activity within the Organization

Charges

The activity A charge with Others amounted to Rs. 1.50 Cr with Charge ID 101170708 was registered on 24 Sep 2025. was completed.
24 Sep 2025
Charges

Progress on A charge with Others of Rs. 30.00 Cr registered on 07 Feb 2023 with Charge ID 100693118 was modified on 24 Sep 2025. was documented.
24 Sep 2025
Director Appointment

Progress on Sandeep Kumar Daga was appointed as a Director was appointed as a Director on 30 May 2025 & has been associated with this company since 8 months 14 days . was documented.
30 May 2025
Charges

A charge with Others amounted to Rs. 6.65 Cr with Charge ID 101008332 was registered on 22 Nov 2024. was recorded as a recent event.
22 Nov 2024
Charges

A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100995451 was registered on 01 Oct 2024. was recorded as a recent event.
01 Oct 2024
Director Appointment

The activity Shilpa Bung was appointed as a Director was appointed as a Director on 01 Oct 2024 & has been associated with this company since 1 year 4 months . was completed.
01 Oct 2024

Explore recent activity and updates - View Recent Activity